Literature DB >> 15837111

Issues in the management of HIV-related tuberculosis.

William J Burman1.   

Abstract

This article focuses on the ways in which HIV infection and the associated immunodeficiency affect the management of active tuberculosis. Controversies in the management of HIV-related tuberculosis can be grouped into issues about tuberculosis treatment itself and issues posed by the use of combination antiretroviral therapy. The author reviews these controversies and makes recommendations for the management of HIV-related tuberculosis.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15837111     DOI： 10.1016/j.ccm.2005.02.002

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  15 in total

1.  Recent advances in tuberculosis: New drugs and treatment regimens.

Authors:  Derek J Sloan; Geraint R Davies; Saye H Khoo
Journal:  Curr Respir Med Rev       Date:  2013-06-01

2.  T-SPOT.TB: an in vitro diagnostic assay measuring T-cell reaction to Mycobacterium tuberculosis-specific antigens.

Authors:  Antona J Wagstaff; Jean-Pierre Zellweger
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  Vertically transmitted HIV infection having first clinical manifestations at 13 y of age.

Authors:  Amitabh Sagar; Biju Vasudevan
Journal:  Indian J Pediatr       Date:  2011-12-29       Impact factor: 1.967

Review 4.  Current development and future prospects in chemotherapy of tuberculosis.

Authors:  Eric L Nuermberger; Melvin K Spigelman; Wing Wai Yew
Journal:  Respirology       Date:  2010-06-04       Impact factor: 6.424

5.  Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen.

Authors:  Margaret Lartey; Kwamena W Sagoe; Hongmei Yang; Ernest Kenu; Fafa Xexemeku; Joseph Oliver-Commey; Vincent Boima; Markafui Seshie; Augustine Sagoe; Julius A A Mingle; Timothy P Flanigan; Hulin Wu; Awewura Kwara
Journal:  Clin Infect Dis       Date:  2011-01-20       Impact factor: 9.079

Review 6.  Interventions for Neurocognitive Dysfunction.

Authors:  Jacqueline Ellero; Michal Lubomski; Bruce Brew
Journal:  Curr HIV/AIDS Rep       Date:  2017-02       Impact factor: 5.071

Review 7.  Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit all.

Authors:  Awewura Kwara; Geetha Ramachandran; Soumya Swaminathan
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-01       Impact factor: 4.481

Review 8.  Treatment Options for HIV-Associated Tuberculosis.

Authors:  Philip Chukwuka Onyebujoh; Isabela Ribeiro; Christopher Curtis Whalen
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

Review 9.  Management of individuals requiring antiretroviral therapy and TB treatment.

Authors:  Karen Cohen; Graeme Meintjes
Journal:  Curr Opin HIV AIDS       Date:  2010-01       Impact factor: 4.283

10.  Anti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia: nested case-control study.

Authors:  Alima Hassen Ali; Tefera Belachew; Alemeshet Yami; Wubeante Yenet Ayen
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.